Home›People›Travis Murdoch
TM

Travis Murdoch

Director at Ollin Biosciences.

Director
Updated Nov 10, 2026·Latest SEC filing Jun 24, 2026·Suggest an edit

About Travis Murdoch

Travis Murdoch is a director at Ollin Biosciences.

Experience

This experience comes from Travis Murdoch's profile and from SEC filings. For roles taken from filings, the years are when the filings name Travis Murdoch in the role, so the role may have started earlier or lasted longer.

Braveheart Bio Current
CEO and President
2025 – Present
Ollin Biosciences, Inc. Current
Board Member & Co-Founder
2022 – Present · Austin, TX
Develops treatments for people with diseases that threaten their vision.
HI-Bio: A Biogen Company
Head of Biogen West Coast Hub
2021 – 2025
Monograph Capital
Partner
2021 – 2025
Guardant Health AMEA
Board Member
2019 – 2022
SoftBank Investment Advisers
Advisor
2018 – 2022
Relay Therapeutics
Board Observer
2019 – 2020
Third Rock Ventures
Principal
2017 – 2018
Ambys Medicines
Founding Team
2017 – 2018
Rheos Medicines
Founding Team
2017 – 2018
Alberta Health Services
Gastroenterologist and Internist
2013 – 2018
McKinsey & Company
McKinsey
2015 – 2017
University of Calgary
Gastroenterology and Inflammatory Bowel Disease
2012 – 2015
University of Toronto
Internal Medicine
2009 – 2012

Key Colleagues at Startups

The people Travis Murdoch works with at each company, as listed on that company's latest Form D.

Ollin Biosciences, Inc. · Form D, Jun 24, 2026
FC
Fred Cohen
Director
AH
Alaa Halawa
Director
CC
JE
Jason Ehrlich
Co-founder and Chief Executive Officer, director
PB
Paul Berns
Director
JC
Jason Coloma
Director

Sources

  1. SECOllin Biosciences, Inc. Form D, filed Jun 24, 2026